Sanofi SA (SNY)
49.01
-0.45
(-0.91%)
USD |
NASDAQ |
May 03, 16:00
49.00
-0.02
(-0.03%)
After-Hours: 20:00
Sanofi Gross Profit (Quarterly): 8.341B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.341B |
December 31, 2023 | 8.780B |
September 30, 2023 | 9.643B |
June 30, 2023 | 8.084B |
March 31, 2023 | 8.360B |
December 31, 2022 | 7.896B |
September 30, 2022 | 9.376B |
June 30, 2022 | 7.980B |
March 31, 2022 | 8.049B |
December 31, 2021 | 7.937B |
September 30, 2021 | 8.949B |
June 30, 2021 | 7.456B |
March 31, 2021 | 7.474B |
June 30, 2020 | 6.344B |
March 31, 2020 | 7.119B |
December 31, 2019 | 7.261B |
September 30, 2019 | 7.547B |
June 30, 2019 | 6.980B |
March 31, 2019 | 6.924B |
December 31, 2018 | 7.060B |
September 30, 2018 | 7.804B |
June 30, 2018 | 6.879B |
March 31, 2018 | 6.856B |
December 31, 2017 | 6.957B |
September 30, 2017 | 7.689B |
Date | Value |
---|---|
June 30, 2017 | 6.654B |
March 31, 2017 | 6.511B |
December 31, 2016 | 6.699B |
September 30, 2016 | 7.276B |
June 30, 2016 | 6.536B |
March 31, 2016 | 6.046B |
December 31, 2015 | 5.069B |
September 30, 2015 | 7.426B |
June 30, 2015 | 6.697B |
March 31, 2015 | 6.379B |
December 31, 2014 | 6.017B |
September 30, 2014 | 7.957B |
June 30, 2014 | 7.596B |
March 31, 2014 | 7.410B |
December 31, 2013 | 5.881B |
September 30, 2013 | 7.485B |
June 30, 2013 | 7.070B |
March 31, 2013 | 7.405B |
December 31, 2012 | 7.517B |
September 30, 2012 | 7.951B |
June 30, 2012 | 8.204B |
March 31, 2012 | 8.280B |
December 31, 2011 | 8.308B |
September 30, 2011 | 8.872B |
June 30, 2011 | 8.531B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
6.344B
Minimum
Jun 2020
9.643B
Maximum
Sep 2023
7.976B
Average
7.959B
Median
Gross Profit (Quarterly) Benchmarks
AstraZeneca PLC | 10.46B |
GSK PLC | 6.840B |
Regeneron Pharmaceuticals Inc | 2.711B |
Cellectis SA | 0.116M |
Denali Therapeutics Inc | -- |